Abstract:Significance Pathological tau accumulation is implicated in a variety of neurodegenerative diseases, including frontotemporal dementia and Alzheimer’s disease. Based on a large-scale forward genetic screen in Drosophila , our study highlights a modifier of tau neurotoxicity, the enzyme biotinidase. Our results suggest that biotin status may represent a druggable metabolic pathway and a potential therapeutic approach to neuroprotection in human tauopathies.

Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model